InvestSMART

pSivida Limited (ASX: PSD) - Announcements

DELISTED - Current share price for PSD : $0.093

ASX company news and announcements for pSivida Limited (PSD) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All pSivida Limited (PSD) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than pSivida Limited (PSD), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for pSivida Limited (PSD)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- pSivida raises A$21m in sale of American Depositary Shares 2 Jul 2007 7:41AM $0.155 $0.093 fallen by 40%
- Signs new agreement for cardiovascular drug delivery 28 Jun 2007 11:47AM $0.160 $0.093 fallen by 41.88%
- Redeems Convertible Note Debt 16 May 2007 9:23AM $0.200 $0.093 fallen by 53.50%
- Commitments Test Entity - Third Quarter Report 30 Apr 2007 2:44PM $0.185 $0.093 fallen by 49.73%
- Medidur passes halfway stage of Phase III trial for DME 24 Apr 2007 8:30AM $0.215 $0.093 fallen by 56.74%
- Open Briefing - MD on Licensing Deal and Note Redemption 19 Apr 2007 9:43AM $0.210 $0.093 fallen by 55.71%
- pSivida Sells AION Diagnostics Subsidiary 13 Apr 2007 9:34AM $0.215 $0.093 fallen by 56.74%
- pSivida announces A$11million private placement 5 Apr 2007 9:29AM $0.250 $0.093 fallen by 62.80%
- Signs $203m Licensing Deal with Pfizer 4 Apr 2007 11:11AM $0.285 $0.093 fallen by 67.37%
- pSivida redeems Sandell Convertible Note 4 Apr 2007 9:51AM $0.285 $0.093 fallen by 67.37%
- Trading Halt 2 Apr 2007 9:52AM n/a $0.093 n/a
- Response to ASX Share Price Query 29 Mar 2007 3:21PM $0.270 $0.093 fallen by 65.56%
- Half Yearly Report & Half Year Accounts 28 Feb 2007 6:15PM $0.225 $0.093 fallen by 58.67%
- A$11.5m (US$9m) Placement 19 Feb 2007 9:38AM $0.245 $0.093 fallen by 62.04%
- Commitments Test Entity - Second Quarter Report 31 Jan 2007 6:34PM $0.235 $0.093 fallen by 60.43%
- Retisert given streamlined Medicare reimbursement 30 Jan 2007 9:41AM $0.210 $0.093 fallen by 55.71%
- Signs drug delivery licensing agreement with Faber 9 Jan 2007 10:06AM $0.250 $0.093 fallen by 62.80%
- Released from Loan Covenant 2 Jan 2007 2:46PM $0.250 $0.093 fallen by 62.80%
- Enters licensing negotiations with Big Pharma 27 Dec 2006 9:34AM $0.250 $0.093 fallen by 62.80%
- Reinstatement to Official Quotation 20 Dec 2006 12:07PM $0.260 $0.093 fallen by 64.23%
- Completes $3.7m Placement 20 Dec 2006 12:07PM $0.225 $0.093 fallen by 58.67%
- Suspension from Official Quotation 19 Dec 2006 10:48AM $0.260 $0.093 fallen by 64.23%
- Trading Halt 15 Dec 2006 1:01PM n/a $0.093 n/a
- Transdermal Drug Delivery Program 20 Nov 2006 9:21AM $0.260 $0.093 fallen by 64.23%
- Signs MOU with Nordic Biotech for $33.7m 13 Nov 2006 10:08AM $0.270 $0.093 fallen by 65.56%

26 - 50 of 141 results

Page 2 of 6

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.